Health Care: Drugs

Alexza Pharmaceuticals Inc (ALXA: NASDAQ)

$1.13 -0.05 | -4.24%
08/28/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 5.56M 47.84M 4.07M 5.66M
Cost of Sales 10.15M 6.81M 0.00 0.00
Gross Operating Profit -4.59M 41.03M 4.07M 5.66M
Selling, General, and Administrative Expenses 13.34M 15.78M 11.09M 11.77M
Research & Development 13.75M 19.08M 21.85M 28.26M
Operating Income before D & A (EBITDA) -31.68M 6.17M -28.87M -34.37M
Depreciation & Amortization 5.77M 4.40M 4.78M 5.24M
Interest Income 13.00K 0.00 420.00K 26.00K
Other Income - Net 8.15M -39.89M 1.90M -4.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -29.29M -38.12M -31.34M -43.58M
Interest Expense 7.44M 1.50M 1.43M 2.19M
Pre-Tax Income -36.73M -39.62M -32.76M -45.77M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -36.73M -39.62M -27.98M -40.53M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -36.73M -39.62M -27.98M -40.53M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -36.73M -39.62M -27.98M -40.53M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-36.73M -39.62M -27.98M -40.53M
Preferred Dividends
Net Income Available To Common -36.73M -39.62M -27.98M -40.53M
Basic EPS from Continuing Ops. -2.07 -2.38 -2.24 -5.97
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.07 -2.38 -2.24 -5.97
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 -0.03
Basic EPS, Total -2.07 -2.38 -2.24 -6.00
Basic Normalized Net Income/Share -2.07 -2.38 -2.24 -5.97
EPS fr Continuing Ops. -2.07 -2.38 -2.24 -5.97
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.07 -2.38 -2.24 -5.97
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 -0.03
EPS, Total -2.07 -2.38 -2.24 -6.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.07 -2.38 -2.24 -5.97
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALXA

Latest ALXA Headlines from TheStreet

More Financial News for ALXA

Press Releases for ALXA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter